Meg Marshall

2022

In 2022, Meg Marshall earned a total compensation of $922.1K as Chief Medical Officer at Barinthus Biotherapeutics plc., a 71% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$157,310
Option Awards$260,014
Salary$462,676
Other$42,055
Total$922,055
50.18%

Marshall received $462.7K in salary, accounting for 50% of the total pay in 2022.

Marshall also received $157.3K in non-equity incentive plan, $260K in option awards and $42.1K in other compensation.

Rankings

In 2022, Meg Marshall's compensation ranked 3,211th out of 5,758 executives tracked by ExecPay. In other words, Marshall earned more than 44.2% of executives.

ClassificationRankingPercentile
All
3,211
out of 5,758
44th
Division
Manufacturing
1,806
out of 3,135
42nd
Major group
Chemicals And Allied Products
858
out of 1,421
40th
Industry group
Drugs
802
out of 1,322
39th
Industry
Pharmaceutical Preparations
585
out of 968
40th
Source: SEC filing on March 29, 2023.

Marshall's colleagues

We found three more compensation records of executives who worked with Meg Marshall at Barinthus Biotherapeutics plc. in 2022.

2022

William Enright

Barinthus Biotherapeutics plc.

Chief Executive Officer

2022

Graham Griffiths

Barinthus Biotherapeutics plc.

Chief Business Officer

2022

Thomas Evans

Barinthus Biotherapeutics plc.

Chief Scientific Officer

News

You may also like